Fungal microbiota composition in Inflammatory Bowel Disease patients in a Norwegian cohort: characterization of disease phenotypes and correlation with clinical activity and disease course

被引：0
|
作者：
Catalan-Serra, I. [1 ,2 ,3 ,4 ]
Thorsvik, S. [4 ,5 ,6 ]
Beisvag, V. [3 ]
Bruland, T. [3 ]
Underhill, D. [4 ,7 ]
Sandvik, A. K. [3 ,4 ,5 ,6 ]
Granlund, A. Van Beelen [3 ,4 ,5 ,6 ]
机构：
[1] Nord Trondelag Hosp Trust, Levanger Hosp, Dept Med Gastroenterol, Levanger, Norway
[2] Nord Trondelag Hosp Trust, Dept Gastroenterol, Trondheim, Spain
[3] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway
[4] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res CEMIR, Trondheim, Norway
[5] St Olavs Hosp, Gastroenterol, Trondheim, Norway
[6] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA USA
[7] Cedars Sinai Med Ctr, Div Immunol Res, Los Angeles, CA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P712
引用
收藏
页码：I608 / I609
页数：2
相关论文
共 50 条
  • [31] The microbiota in inflammatory bowel disease
    Sheehan, Donal
    Moran, Carthage
    Shanahan, Fergus
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (05) : 495 - 507
  • [32] The microbiota in inflammatory bowel disease
    Donal Sheehan
    Carthage Moran
    Fergus Shanahan
    Journal of Gastroenterology, 2015, 50 : 495 - 507
  • [33] Correlation Between Serological Biomarkers and Clinical Activity in Patients With Inflammatory Bowel Disease (IBD)
    Chaparro, Maria
    Miranda-Garcia, Pablo
    Gisben, Javier P.
    GASTROENTEROLOGY, 2011, 140 (05) : S425 - S425
  • [34] Correlation Between Serological Biomarkers and Clinical Activity in Patients With Inflammatory Bowel Disease (IBD)
    Miranda-Garcia, Pablo
    Chaparro, Maria
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2012, 142 (05) : S654 - S654
  • [35] Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease
    De Cruz, Peter
    Prideaux, Lani
    Wagner, Josef
    Ng, Siew C.
    McSweeney, Chris
    Kirkwood, Carl
    Morrison, Mark
    Kamm, Michael A.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (02) : 372 - 390
  • [36] THE EFFECT OF VEDOLIZUMAB ON COLONIC MICROBIOTA COMPOSITION IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE
    Altomare, Annamaria
    Rocchi, Giulia
    Balestrieri, Paola
    Tullio, Alessandro
    Putignani, Lorenza
    Gori, Manuele
    Guarino, Michele Pier Luca
    Cicala, Michele
    GASTROENTEROLOGY, 2023, 164 (06) : S918 - S919
  • [37] Clinical assessment of disease activity for canine inflammatory bowel disease
    Jergens, Albert E.
    JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 2004, 40 (06) : 437 - 445
  • [38] THE EFFECT OF VEDOLIZUMAB ON COLONIC MICROBIOTA COMPOSITION IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE
    Altomare, A.
    Rocchi, G.
    Balestrieri, P.
    Tullio, A.
    Putignani, L.
    Gori, M.
    Guarino, M. P. L.
    Cicala, M.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S179 - S179
  • [39] Clinical outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
    Wetwittayakhlang, P.
    Albader, F.
    Golovics, P.
    Hahn, G. Drugg
    Bessissow, T.
    Bitton, A.
    Afif, W.
    Wild, G.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I077 - I078
  • [40] Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
    Wetwittayakhlang, Panu
    Albader, Farah
    Golovics, Petra A.
    Hahn, Gustavo Druegg
    Bessissow, Talat
    Bitton, Alain
    Afif, Waqqas
    Wild, Gary
    Lakatos, Peter L.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 2021
12345